Wat betsjut "Dúdlik"?
It bist draacht de mutaasje net. It sil de sykte net ûntwikkelje en sil it net trochjaan.
Progressive Retinal Atrophy 2 (GR-PRA2) is a hereditary eye disease affecting Golden Retrievers, leading to vision loss and eventual blindness. Early detection through a DNA test is crucial for responsible breeding and pet ownership. This genetic test identifies carriers of the GR-PRA2 mutation, allowing owners to make informed decisions about their dog's health. By screening breeding stock, we can reduce the prevalence of this condition in future generations. Regular eye check-ups and genetic testing can ensure your Golden Retriever enjoys a healthy, vibrant life. Protect your furry friend from GR-PRA2 by opting for a reliable DNA test today. Stay proactive and safeguard your dog's vision!
Progressive Retinal Atrophy 2 (GR-PRA2) is a hereditary eye disorder affecting Golden Retrievers, leading to gradual vision loss and potential blindness. This condition is caused by a specific genetic mutation, which can be identified through a simple DNA test. Early detection is crucial for managing the health of affected dogs and making informed breeding decisions. Responsible breeders often screen for GR-PRA2 to reduce the incidence of this condition in future generations. Owners are encouraged to consider genetic testing to ensure the well-being of their pets.
Dizze DNA-test is opnommen fanôf ús pakket Basic - en is ek diel fan 'e pakketten Basic, Standard, Advanced, Complete.
Besjoch DNA-testpakketten →Progressive Retinal Atrophy 2 (GR-PRA2) is a hereditary eye condition that primarily affects Golden Retrievers. This progressive disease leads to the gradual degeneration of the retina, which is the light-sensitive layer at the back of the eye. The condition typically results in vision loss, which may begin with night blindness and can eventually lead to complete blindness.
GR-PRA2 is caused by mutations in a specific gene that plays a crucial role in the health and function of photoreceptor cells in the retina. These cells are responsible for detecting light and enabling vision. As the disease progresses, the photoreceptor cells deteriorate, affecting the dog's ability to perceive visual stimuli effectively.
Dogs affected by GR-PRA2 may exhibit a range of symptoms related to vision impairment. Initially, owners may notice that their pet has difficulty seeing in low-light conditions, such as during the evening or in dimly lit areas. As the condition advances, dogs may also struggle with daytime vision, bumping into objects or displaying hesitance when navigating their surroundings. Other signs may include increased anxiety in unfamiliar environments, reluctance to engage in activities that require good vision, and changes in behavior due to frustration or confusion.
Early detection of GR-PRA2 is crucial for managing the condition effectively. Regular veterinary check-ups and eye examinations can help identify the onset of retinal degeneration. While there is currently no cure for GR-PRA2, early diagnosis allows pet owners to make necessary adjustments in their dog's environment and lifestyle to enhance their quality of life as their vision changes.
While there is no definitive treatment for GR-PRA2, several strategies can help manage the condition and support affected dogs. Creating a safe, predictable environment is essential, as this can help dogs navigate their surroundings more easily. Owners are encouraged to maintain consistent routines and minimize changes in furniture layout to reduce confusion. Training and socialization can also assist dogs in adapting to their vision loss, fostering confidence and independence.
Progressive Retinal Atrophy 2 (GR-PRA2) is a significant concern for Golden Retriever owners, impacting the dog's vision and overall quality of life. Awareness of the condition, along with proactive measures for early detection and supportive management, can help enhance the well-being of affected dogs. Through understanding and care, owners can ensure that their pets continue to live fulfilling lives despite the challenges posed by this hereditary eye condition.
It bist draacht de mutaasje net. It sil de sykte net ûntwikkelje en sil it net trochjaan.
Nee, it bist is oer it algemien sûn, mar kin de mutaasje oerjaan oan har neiteam.
It draacht twa mutearre eksimplaren. Klinyske tekens wurde ferwachte ôfhinklik fan de sykte. It moat net fokt wurde.
Guon sykten binne seks-keppele, sadat harren útdrukking fariearret ôfhinklik fan de bist syn seks.
This DNA test detects the mutation associated with Progressive Retinal Atrophy 2 In Golden Retriever (GR-PRA2) in order to identify clear, carrier, or at-risk animals.
DNA-testen helpt fokkers om feiliger parings te plannen en it risiko te ferminderjen fan it oerdragen fan de mutaasje nei neiteam.
De erflike modus rapportearre foar dizze test is Autosomal Recessive.
This test analyses the mutation TTC8 c.669delA.
Net needsaaklik. Ynterpretaasje hinget ôf fan it erflik patroan en de resultearjende genotyp.
Downs Louise M, WallinHåkansson Berit, Bergström Tomas, Mellersh Cathryn S. A novel mutation in TTC8 is associated with progressive retinal atrophy in the golden retriever. Canine Genet Epidemiol. 2014 Apr 16;1:4. doi: 10.1186/2052-6687-1-4. eCollection 2014.
Jo privacy, jo kar
Wy brûke essensjele cookies om de webside út te fieren. Opsjonele cookies (lykas oanbieders fan ynbêde ynhâld) binne standert útskeakele en binne allinich ynskeakele as jo it iens binne. Jo kinne jo kar op elk momint feroarje mei de knop "Koekjes".
Fereaske foar kearnfunksjes en feiligens. Altyd ynskeakele.
Ferbetteret funksjes lykas foarkarbesparring of net-reklame-ynbêden.
Helpt ús sitegebrûk te begripen. Standert útskeakele.
Advertearje / folgjen oer siden (guon fideo / kaarten ynbêde). Standert útskeakele.